BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16720337)

  • 1. Mechanisms controlling CDK9 activity.
    Marshall RM; Grana X
    Front Biosci; 2006 Sep; 11():2598-613. PubMed ID: 16720337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
    Dow EC; Liu H; Rice AP
    J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE.
    Paparidis NF; Durvale MC; Canduri F
    Mol Biosyst; 2017 Jan; 13(2):246-276. PubMed ID: 27833949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular control of gene expression by T-type cyclin/CDK9 complexes.
    Garriga J; Graña X
    Gene; 2004 Aug; 337():15-23. PubMed ID: 15276198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.
    Zhou M; Huang K; Jung KJ; Cho WK; Klase Z; Kashanchi F; Pise-Masison CA; Brady JN
    J Virol; 2009 Jan; 83(2):1036-44. PubMed ID: 18971272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-TEFb goes viral.
    Zaborowska J; Isa NF; Murphy S
    Bioessays; 2016 Jul; 38 Suppl 1():S75-85. PubMed ID: 27417125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
    Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
    J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK9 keeps RNA polymerase II on track.
    Egloff S
    Cell Mol Life Sci; 2021 Jul; 78(14):5543-5567. PubMed ID: 34146121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription.
    Sabò A; Lusic M; Cereseto A; Giacca M
    Mol Cell Biol; 2008 Apr; 28(7):2201-12. PubMed ID: 18250157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional inactivation of Cdk9 through oligomerization chain reaction.
    Napolitano G; Mazzocco A; Fraldi A; Majello B; Lania L
    Oncogene; 2003 Jul; 22(31):4882-8. PubMed ID: 12894230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of cyclin T1/CDK9 complexes during T cell activation.
    Garriga J; Peng J; Parreño M; Price DH; Henderson EE; Graña X
    Oncogene; 1998 Dec; 17(24):3093-102. PubMed ID: 9872325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription.
    Fu TJ; Peng J; Lee G; Price DH; Flores O
    J Biol Chem; 1999 Dec; 274(49):34527-30. PubMed ID: 10574912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-driven cyclin-dependent kinase regulation: when CDK9/cyclin T subunits of P-TEFb meet their ribonucleoprotein partners.
    Michels AA; Bensaude O
    Biotechnol J; 2008 Aug; 3(8):1022-32. PubMed ID: 18655042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-actin participates in RNA polymerase II-dependent transcription elongation by recruiting positive transcription elongation factor b (P-TEFb).
    Qi T; Tang W; Wang L; Zhai L; Guo L; Zeng X
    J Biol Chem; 2011 Apr; 286(17):15171-81. PubMed ID: 21378166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription.
    Jang MK; Mochizuki K; Zhou M; Jeong HS; Brady JN; Ozato K
    Mol Cell; 2005 Aug; 19(4):523-34. PubMed ID: 16109376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-TEFb regulation of transcription termination factor Xrn2 revealed by a chemical genetic screen for Cdk9 substrates.
    Sansó M; Levin RS; Lipp JJ; Wang VY; Greifenberg AK; Quezada EM; Ali A; Ghosh A; Larochelle S; Rana TM; Geyer M; Tong L; Shokat KM; Fisher RP
    Genes Dev; 2016 Jan; 30(1):117-31. PubMed ID: 26728557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of multiple cyclin subunits of human P-TEFb.
    Peng J; Zhu Y; Milton JT; Price DH
    Genes Dev; 1998 Mar; 12(5):755-62. PubMed ID: 9499409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic activity of Cdk9 is required for nuclear co-localization of the Cdk9/cyclin T1 (P-TEFb) complex.
    Napolitano G; Majello B; Lania L
    J Cell Physiol; 2003 Oct; 197(1):1-7. PubMed ID: 12942536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis.
    Iankova I; Petersen RK; Annicotte JS; Chavey C; Hansen JB; Kratchmarova I; Sarruf D; Benkirane M; Kristiansen K; Fajas L
    Mol Endocrinol; 2006 Jul; 20(7):1494-505. PubMed ID: 16484339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of P-TEFb elongation complex activity by CDK9 acetylation.
    Fu J; Yoon HG; Qin J; Wong J
    Mol Cell Biol; 2007 Jul; 27(13):4641-51. PubMed ID: 17452463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.